Pfizer Announces Availability Of Quillivant XR (methylphenidate hydrochloride) CII For Extended-Release Oral Suspension In The United States

The First Once-Daily, Extended-Release Liquid Medication
for the Treatment of ADHD is Now Available in
Pharmacies

NEW YORK--(BUSINESS WIRE)--Jan 14, 2013 - Pfizer Inc. (NYSE:
PFE) today announced that Quillivant XR™...

Source: Drugs.com - Pharma News - January 14, 2013 Category: Pharmaceuticals Source Type: news